A pioneer in viral vectors engineering, we have one ambition: design innovative treatments in the fight against cancer.

Our approach uses the mechanisms of the immune response to enable the patient’s body to fight against disease. At Transgene, we integrate genetic sequences (or transgenes) into viral vectors to transform them into weapons that can kill abnormal cells.

Transgene’s immunotherapeutics can be administered as single agents or in combination with other treatments (immunotherapy, chemotherapy, etc.).

Transgene news

Contact supplier